Ginkgo Bioworks Holdings (DNA)

NYSE HEALTHCARE
$9.09 -6.58% RSI 48 Neutral Add Alert

Moving Averages

SMA 200
$9.29
Price near

Company Profile

Ginkgo Bioworks Holdings (DNA) is a leader in synthetic biology, specializing in advanced genetic engineering to develop tailor-made bioengineered organisms for diverse applications, including pharmaceuticals, agriculture, and industrial biotech. Its cutting-edge platform enhances cellular design for efficient manufacturing processes, positioning the company to meet pressing global challenges such as climate change and food security. Ginkgo's unique capabilities and focus on sustainable biotechnology solutions not only address growing market demands for bio-based alternatives but also signify a compelling growth trajectory, underscoring its potential to drive transformative impact across multiple industries.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$593.80M
P/E Ratio
None
EPS
$-5.38
Beta
1.778
Dividend Yield
0.00%
52-Week High
$17.58
52-Week Low
$5.37

Similar stocks in BIOTECHNOLOGY

Data last updated: July 13, 2026 at 1:41 AM EDT

Track DNA for free

Get e-mail RSI alerts when Ginkgo Bioworks Holdings enters oversold or overbought territory. Free forever.

Add Alert